What caused the B8F.DE stock surge today?

The intraday spike to **€6.80** came with heavy volume but no firm company release in the provided feeds. Such moves often follow speculative flows, block trades, or third-party commentary. Check Biofrontera’s official news page for any confirmation.

What is Meyka AI’s short-term forecast for B8F.DE stock?

Meyka AI's forecast model projects a near-term reference target of **€8.50**, an implied upside of **24.95%** versus the current **€6.80**. Models are projections and do not guarantee outcomes.

Is B8F.DE stock a buy for long-term investors?

Meyka AI assigns a C+ grade and suggests HOLD. Fundamentals show negative EPS and mixed valuation metrics. Long-term investors should wait for clearer earnings recovery and confirmed strategic catalysts before adding exposure.

How liquid is B8F.DE stock for trading?

Liquidity is uneven: average volume is **605.00** but today's volume reached **45,797.00**, creating large short-term swings. Use small position sizes and monitor spreads when trading intraday.

DE Stocks

B8F.DE Biofrontera AG XETRA 19 Jan 2026: Intraday surge to €6.80 on heavy volume, watch targets

ByDanny Kontos January 19, 2026January 19, 2026

B8F.DE stock led intraday volume movers as Biofrontera AG climbed to €6.80 on XETRA in Germany on 19 Jan 2026. The move followed a low of €0.30 earlier in the session and traded 45,797.00 shares by mid-session, far above the 605.00 average. Traders pushed price averages toward the 50-day level of €6.53, while the 200-day average remains €9.19. We assess why volume spiked, what fundamentals say about value, and short-term price targets for active traders and holders.